Sold as Razadyne, Razadyne Er. Every FDA application for this active ingredient: 3 branded and 22 generic.
As of Nov 15, 2026, FDA lists 25 applications for Galantamine Hydrobromide (sold as Razadyne, Razadyne Er), first approved Feb 28, 2001, with 0 new uses approved and 0 published complete response letters.
| Feb 28, 2001 | RazadyneNDA 21169 · New molecular entity | Janssen Pharms | 20 | Discontinued |
| Jun 22, 2001 | RazadyneNDA 21224 · New dosage form | Janssen Pharms | 16 | Discontinued |
| Apr 1, 2005 | Razadyne ErNDA 21615 · New dosage form | Janssen Pharms | 17 | Discontinued |
| Aug 28, 2008 | Galantamine HydrobromideANDA 77603 | Pharmobedient | 1 | Discontinued |
| Aug 28, 2008 | Galantamine HydrobromideANDA 77605 | Barr | 6 | Marketed |
| Sep 11, 2008 | Galantamine HydrobromideANDA 77593 | Pharmazone | 0 | Marketed |
| Sep 15, 2008 | Galantamine HydrobromideANDA 78189 | Barr | 7 | Marketed |
| Dec 15, 2008 | Galantamine HydrobromideANDA 79028 | Watson Labs | 4 | Marketed |
| Jan 30, 2009 | Galantamine HydrobromideANDA 78185 | Hikma | 6 | Marketed |
| Feb 6, 2009 | Galantamine HydrobromideANDA 77604 | Yabao Pharm | 3 | Marketed |
| Feb 11, 2009 | Galantamine HydrobromideANDA 77608 | Hikma | 6 | Discontinued |
| May 27, 2009 | Galantamine HydrobromideANDA 78484 | Impax Labs | 3 | Discontinued |
| May 29, 2009 | Galantamine HydrobromideANDA 77590 | Mylan | 5 | Discontinued |
| Jun 22, 2009 | Galantamine HydrobromideANDA 77589 | Sandoz | 1 | Marketed |
| Jul 9, 2009 | Galantamine HydrobromideANDA 77587 | Chartwell Rx | 2 | Discontinued |
| Sep 15, 2009 | Galantamine HydrobromideANDA 77585 | Heritage Pharma | 1 | Discontinued |
| Jan 24, 2011 | Galantamine HydrobromideANDA 90900 | Pharmobedient | 4 | Discontinued |
| Feb 2, 2011 | Galantamine HydrobromideANDA 90178 | Sun Pharm | 7 | Marketed |
| Feb 17, 2011 | Galantamine HydrobromideANDA 78898 | Zydus Pharms USA Inc | 7 | Marketed |
| Mar 29, 2011 | Galantamine HydrobromideANDA 90957 | Aurobindo Pharma Ltd | 7 | Marketed |
| Sep 27, 2011 | Galantamine HydrobromideANDA 77781 | Apotex Inc | 8 | Discontinued |
| Aug 5, 2016 | Galantamine HydrobromideANDA 204895 | Aurobindo Pharma | 5 | Marketed |
| — | Galantamine HydrobromideANDA 77588 | Ranbaxy | 0 | Discontinued |
| — | Galantamine HydrobromideANDA 77592 | Sun Pharm Inds | 0 | Discontinued |
| — | Galantamine HydrobromideANDA 77767 | Watson Labs | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA